QT dispersion in patients with Churg-Strauss syndrome.

Background: Churg-Strauss syndrome (CSS) is a rare, systemic necrotising small and middle-sized vessel vasculitis, accompanied by blood eosinophilia, eosinophil infiltration of various tissues and bronchial asthma. Cardiac injury caused by myocardial eosinophilic infiltration and/or vasculitis in CSS seems to be very common. Active inflammatory process accompanied by myocardial fibrosis has been described in this population even despite disease remission.

The course of asthma in Churg-Strauss syndrome.

Objectives: Asthma is one of the key features of Churg-Strauss syndrome (CSS); however its course in the disease is unclear. The aim of this study was to analyze the asthma course in CSS patients.

Patients And Methods: We conducted a retrospective study of 22 CSS patients.

[The influence of leukotriene receptor antagonists treatment on Churg-Strauss syndrome].

Introduction: Churg-Strauss syndrome (CSS) is a rare, systemic, necrotizing, small- and middle-sized vessel vasculitis which is accompanied by blood eosinophilia, eosinophil infiltration of various tissues and bronchial asthma. Leukotriene receptor antagonists (LTRAs) may participate in the pathogenesis of the disease.

Aim Of The Study: The aim of this study was a retrospective evaluation of the influence of LTRAs on the development of CSS and its later course.